Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
First United
FUNC
$283M
| $126K | ﹤0.01% |
+4,218
| New | +$113K |
|
|
MILN
4377
Global X Millennial Consumer ETF
MILN
$100M
| $126K | ﹤0.01% |
3,000
+750
| +33% | +$29.3K |
|
4378
Lifetime Brands
LCUT
$192M
| $124K | ﹤0.01% |
19,016
+5,302
| +39% | +$38.9K |
|
4379
Alto Ingredients
ALTO
$358M
| $123K | ﹤0.01% |
76,703
+42,450
| +124% | +$63.9K |
|
4380
FibroBiologics
FBLG
$4.37M
| $123K | ﹤0.01% |
1,998
+1,567
| +364% | +$104K |
|
4381
Rekor Systems
REKR
$84.6M
| $123K | ﹤0.01% |
104,427
+80,255
| +332% | +$118K |
|
4382
Greenwich LifeSciences
GLSI
$206M
| $123K | ﹤0.01% |
8,560
+6,538
| +323% | +$96.9K |
|
4383
Taboola.com
TBLA
$1.39B
| $122K | ﹤0.01% |
36,431
+33,668
| +1,219% | +$111K |
|
4384
Ultralife
ULBI
$85.9M
| $121K | ﹤0.01% |
13,395
+2,355
| +21% | +$24.3K |
|
4385
Fractyl Health
GUTS
$109M
| $121K | ﹤0.01% |
47,796
+45,219
| +1,755% | +$148K |
|
4386
Kewaunee Scientific
KEQU
$106M
| $121K | ﹤0.01% |
+3,621
| New | +$170K |
|
4387
Invivyd
IVVD
$171M
| $120K | ﹤0.01% |
117,973
+75,780
| +180% | +$82.1K |
|
|
LFT
4388
Lument Finance Trust
LFT
$37.7M
| $120K | ﹤0.01% |
+47,462
| New | +$120K |
|
|
TIXT
4389
DELISTED
TELUS International
TIXT
| $120K | ﹤0.01% |
30,629
+16,629
| +119% | +$74.8K |
|
4390
CarParts.com
PRTS
$42.4M
| $119K | ﹤0.01% |
13,082
-307
| -2% | -$2.9K |
|
4391
Innovator US Equity Power Buffer ETF November
PNOV
$882M
| $118K | ﹤0.01% |
+3,198
| New | +$117K |
|
4392
Waldencast
WALD
$219M
| $118K | ﹤0.01% |
32,436
+24,355
| +301% | +$82.2K |
|
4393
D-Wave Quantum Inc. Common Stock
QBTS
$6.66B
| $118K | ﹤0.01% |
120,029
+89,894
| +298% | +$89.9K |
|
4394
PUT
PureCycle Technologies
PCT
$1.27B
| $118K | ﹤0.01% |
+12,400
| New | +$83K |
|
4395
Expensify
EXFY
$178M
| $117K | ﹤0.01% |
59,847
+2,798
| +5% | +$5.81K |
|
|
MPX
4396
DELISTED
Marine Products Corp
MPX
| $117K | ﹤0.01% |
12,050
+7,636
| +173% | +$73.5K |
|
4397
Gyre Therapeutics
GYRE
$648M
| $116K | ﹤0.01% |
9,288
+6,855
| +282% | +$88.4K |
|
4398
Werewolf Therapeutics
HOWL
$24.3M
| $116K | ﹤0.01% |
54,810
+30,990
| +130% | +$70.5K |
|
4399
Invesco NASDAQ Internet ETF
PNQI
$525M
| $115K | ﹤0.01% |
2,645
| – | – |
|
4400
FT Vest US Equity Buffer ETF April
FAPR
$1.26B
| $115K | ﹤0.01% |
+2,833
| New | +$112K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.